Welcome to episode 9 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and Trevor Abes each deliver a 2.5-minute stock pick related to recent news stories with investment implications.
Here’s Jon’s article for episode 9:
- Alimentation Couche-Tard and 7-Eleven owner sign NDA over $47B acquisition (Stockhouse).
- Jon’s stock pick, Alimentation Couche-Tard (TSX:ATD), is a convenience store and fuel station operator active in 29 countries and territories across almost 17,000 stores. Its flagships brands include Couche-Tard, Circle K and Ingo.
- Couche-Tard stock has given back 5.08 per cent year-over-year but remains up by 75.37 per cent since 2020.
Here are Trevor’s articles:
- Theralase uncovers new use-case for flagship drug (Stockhouse).
- BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient’s Guide (Stockhouse).
- Trevor’s stock pick, Theralase Technologies (TSX:TLT), is a clinical-stage pharmaceutical developer focused on treating various cancers, bacteria and viruses. The company’s strategy focuses on light, radiation, sound and/or drug-activated small molecule compounds and related drug formulations.
- Theralase stock has added 5.88 per cent year-over-year but remains down by 28 per cent since 2020.
Here’s a list of past episodes:
- Episode 1: Lithium and AI.
- Episode 2: Envelopes and space travel.
- Episode 3: Booze and concrete.
- Episode 4: Graphite and GameStop.
- Episode 5: High-flying stocks.
- Episode 6: Shopify and First Mining Gold.
- Episode 7: Galaxy Digital and Liberty Defense.
- Episode 8: Dollarama and Standard Lithium.
Thanks for listening!
Join the discussion: Find out what investors are saying about The 5-Minute Investor Podcast and this week’s stock picks on the Alimentation Couche-Tard Inc. and Theralase Technologies Inc. Bullboards and check out the rest of Stockhouse’s stock forums and message boards.
The 5-Minute Investor is on Spotify, YouTube, iHeartRadio, Podbean, Stockhouse or wherever finer podcasts are found.
The material provided in this podcast is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
(Top image: Adobe Stock)
